872369-16-9

Upstream product

• 109262-86-4 (3S,4S)-1-(benzyloxy)-4-methylhex-5-en-3-ol 
• 872369-17-0 (2R,3S)-5-(benzyloxy)-3-(tert-butyldimethylsilyloxy)-2-methylpentanal 
• 870091-89-7 (-)-(R)-4-benzyl-3-[(2R,3S)-5-(benzyloxy)-3-hydroxy-2-methylpentanoyl]-1,3-oxazolidin-2-one 
• 872369-15-8 (-)-(R)-4-benzyl-3-[(2R,3S)-5-(benzyloxy)-3-(tert-butyldimethylsilyloxy)-2-methylpentanoyl]-1,3-oxazolidin-2-one 
• 19790-60-4 3-Benzyloxypropanal 

Downstream Products

• 911837-48-4 (2S,3R,4S,5S)-7-Benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-4-methyl-2-vinyl-heptane-1,3-diol 
• 911837-39-3 {(1S,2S)-1-(2-Benzyloxy-ethyl)-2-[(4R,5S)-2-(4-methoxy-phenyl)-5-vinyl-[1,3]dioxan-4-yl]-propoxy}-tert-butyl-dimethyl-silane 
• 911837-40-6 (2S,3R,4S,5S)-7-Benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-3-(4-methoxy-benzyloxy)-4-methyl-2-vinyl-heptan-1-ol 
• 911837-38-2 (R)-4-Benzyl-3-[(2R,3S,4S,5S)-7-benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-4-methyl-2-vinyl-heptanoyl]-oxazolidin-2-one 
• 911837-49-5 1-{(1R,2S,3S)-5-Benzyloxy-3-(tert-butyl-dimethyl-silanyloxy)-1-[(S)-1-(tert-butyl-diphenyl-silanyloxymethyl)-allyl]-2-methyl-pentyloxymethyl}-4-methoxy-benzene 
• 911837-50-8 7-benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-2-(tert-butyl-diphenyl-silanyloxymethyl)-3-(4-methoxy-benzyloxy)-4-methyl-heptanal 
• 911837-41-7 7-benzyloxy-5-(tert-butyl-dimethyl-silanyloxy)-2-(tert-butyl-diphenyl-silanyloxymethyl)-3-(4-methoxy-benzyloxy)-4-methyl-heptan-1-ol 
• 911837-43-9 3-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-7-(tert-butyl-diphenyl-silanyloxy)-5-(4-methoxy-benzyloxy)-4-methyl-heptanal 
• 911837-42-8 3-(tert-butyl-dimethyl-silanyloxy)-6-(tert-butyl-dimethyl-silanyloxymethyl)-7-(tert-butyl-diphenyl-silanyloxy)-5-(4-methoxy-benzyloxy)-4-methyl-heptan-1-ol 
• 911837-51-9 1-{(1R,2S,3S)-5-Benzyloxy-3-(tert-butyl-dimethyl-silanyloxy)-1-[(S)-1-(tert-butyl-dimethyl-silanyloxymethyl)-2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-2-methyl-pentyloxymethyl}-4-methoxy-benzene 
• 911837-44-0 5-(tert-butyl-dimethyl-silanyloxy)-8-(tert-butyl-dimethyl-silanyloxymethyl)-9-(tert-butyl-diphenyl-silanyloxy)-7-(4-methoxy-benzyloxy)-2,6-dimethyl-nonane-1,3-diol 
• 911837-55-3 5-(tert-butyl-dimethyl-silanyloxy)-8-(tert-butyl-dimethyl-silanyloxymethyl)-9-(tert-butyl-diphenyl-silanyloxy)-3,7-bis-(4-methoxy-benzyloxy)-2,6-dimethyl-nonanal 
• 911837-54-2 (4S,5S)-4-[(2S,3S,4R,5S)-2-(tert-Butyl-dimethyl-silanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-6-(tert-butyl-diphenyl-silanyloxy)-4-(4-methoxy-benzyloxy)-3-methyl-hexyl]-2-(4-methoxy-phenyl)-5-methyl-[1,3]dioxane 
• 911837-45-1 5-(tert-butyl-dimethyl-silanyloxy)-8-(tert-butyl-dimethyl-silanyloxymethyl)-9-(tert-butyl-diphenyl-silanyloxy)-3,7-bis-(4-methoxy-benzyloxy)-2,6-dimethyl-nonan-1-ol 

Relevant academic research and scientific papers

Synthesis and structure-activity relationship study of FD-891: Importance of the side chain and C8-C9 epoxide for cytotoxic activity against cancer cells

Unified synthesis of FD-891 analogs and their structure-activity relationship are described. By using stereoselective allylation/crotylation and Evans aldol chemistry, six side-chain fragments having different length and terminus were synthesized. These f

Total syntheses of 28,29-diepi-arenamide A, 29-epi-arenamide A, and 28-epi-arenamide A

This communication describes the synthesis of stereochemical analogs of arenamide A, a 19-membered cytotoxic depsipeptide isolated from the fermentation broth of a marine bacterial strain Salinispora arenicola. The key steps are diastereoselective aldol r

Asymmetric synthesis of the C1-C13 fragment of the marine metabolite bistramide K

A synthetic study on the construction of the C1-C13 fragment of bistramide K is described. This unit differs from other members of the bistramide family, which are equipped with a pyran structure at C6-C11. In bistramide K, the linear C1-C13 portion conta

Studies toward the total synthesis of tedanolide: stereoselective synthesis of the C(8)-C(17) segment

The stereoselective synthesis of the C(8)-C(17) sub-unit (-)-5 of tedanolide (1), which involves iterative Evans aldol reactions as the key steps, is described.

Total synthesis of beauveriolide I

The first total synthesis of beauveriolide I (1a), a selective ACAT inhibitor, is described. The key steps in this synthesis involved a diastereoselective aldol condensation sequence and a macrocyclization.